A detailed history of Zullo Investment Group, Inc. transactions in Amgen Inc stock. As of the latest transaction made, Zullo Investment Group, Inc. holds 1,327 shares of AMGN stock, worth $349,239. This represents 0.18% of its overall portfolio holdings.

Number of Shares
1,327
Previous 1,351 1.78%
Holding current value
$349,239
Previous $422,000 1.18%
% of portfolio
0.18%
Previous 0.19%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024

SELL
$309.38 - $337.38 $7,425 - $8,097
-24 Reduced 1.78%
1,327 $427,000
Q2 2024

Aug 13, 2024

SELL
$262.75 - $319.31 $262 - $319
-1 Reduced 0.07%
1,351 $422,000
Q1 2024

Apr 24, 2024

BUY
$268.87 - $324.56 $3,495 - $4,219
13 Added 0.97%
1,352 $384,000
Q4 2023

Jan 19, 2024

SELL
$255.7 - $288.46 $8,949 - $10,096
-35 Reduced 2.55%
1,339 $385,000
Q3 2023

Oct 19, 2023

SELL
$218.65 - $271.46 $4,154 - $5,157
-19 Reduced 1.36%
1,374 $369,000
Q2 2023

Jul 19, 2023

BUY
$214.27 - $253.37 $3,856 - $4,560
18 Added 1.31%
1,393 $309,000
Q1 2023

Apr 25, 2023

BUY
$225.79 - $275.2 $677 - $825
3 Added 0.22%
1,375 $332,000
Q4 2022

Feb 14, 2023

BUY
$229.03 - $291.01 $1,374 - $1,746
6 Added 0.44%
1,372 $360,000
Q3 2022

Nov 08, 2022

BUY
$224.46 - $253.15 $9,427 - $10,632
42 Added 3.17%
1,366 $308,000
Q2 2022

Aug 11, 2022

SELL
$230.71 - $256.74 $2,537 - $2,824
-11 Reduced 0.82%
1,324 $322,000
Q1 2022

May 16, 2022

BUY
$219.27 - $242.57 $657 - $727
3 Added 0.23%
1,335 $323,000
Q4 2021

Feb 16, 2022

BUY
$198.88 - $227.6 $264,908 - $303,163
1,332 New
1,332 $300,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $141B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Zullo Investment Group, Inc. Portfolio

Follow Zullo Investment Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Zullo Investment Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Zullo Investment Group, Inc. with notifications on news.